Vector Laboratories' blog provides a wealth of information on immunohistochemistry (IHC), immunofluorescence (IF), and related life science research topics.
"Vector Laboratories' lectins provide an extremely consistent and cost-effective way to monitor cell-surface sialylation by flow cytometry, meaning we have the confidence that any observed changes reflect the biology rather than variability in an assay... Read more
Immuno-oncology research spans a wide range of biology, from RNA sensing and metabolism to the nervous system and glycosylation, and each new study adds to our understanding of how the immune system interacts with cancer.
Immuno-oncology research often hinges on the ability to characterize complex biological systems—the tumor microenvironment, effector T cells, immune checkpoints, to name a few. Probing these systems requires tools that reliably capture the spatial biology, perform... Read more
When researchers design a protein expression study, the standard toolkit of IHC, IF, flow cytometry, and other techniques can tell them a great deal about where a protein is and how much of it is... Read more
Two Vector scientists were recently interviewed about glycosylation in cancer research and advances in bioconjugation for next-generation therapeutics.
Vector Laboratories will be attending Cancer Glyco-X 2026 to discuss how the right tools reveal glyco-insights in cancer research. Product Manager Shuhui Chen and Sr. Field Application Scientist Sabrina Mateos will be representing Vector Laboratories... Read more
Immune checkpoint therapy describes a class of antibody therapeutics for the treatment of cancer that target proteins that modulate immune responses. More than a dozen approved therapeutics target immune checkpoint proteins like PD-1, PD-L1, and... Read more
Looking Beyond Genes and Proteins Genomics has transformed how we identify disease, and proteomics has expanded how we understand function. But in Congenital Disorders of Glycosylation (CDGs), neither tells the full story. CDGs arise from... Read more
Join us at booth #603 to explore cancer detection, targeting, and biomarker research solutions powered by 50 years of expertise. At the AACR Annual Meeting 2026 in San Diego, Vector Laboratories is showcasing how its... Read more
Probing protein glycosylation uncovers new diagnostic and therapeutic avenues for breast cancer, one of the most common forms of cancer.
